New gut therapy challenges standard stool transplants for dangerous infections
NCT ID NCT05911997
Summary
This study is testing a new, standardized microbial therapy called MTC01 against the current standard treatment, a fecal microbiota transplant (FMT), for people who keep getting repeat C. diff infections. It aims to see if the new treatment is as safe and effective as the stool transplant, which uses bacteria from a healthy donor's gut. The study will enroll 60 adults who have had at least two C. diff infections in the last six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIODIES DIFFICILE INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Icahn School of Medicine at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.